MindMed’s JR Rahn on Using LSD To Treat Mental Health – The Daily Dive
For our Saturday edition of The Daily Dive, host Cassandra [...]
FDA May Allow Trials for Algernon’s Psychedelic DMT
Canada-based Algernon announced its clinical program in January based in part on a preclinical study published last year in Experimental Neurology by researchers from Semmelweis University, which showed DMT can promote neurogenesis and neuroplasticity in a rat model of brain ischemia.
Report Finds People Use Psychedelic Drugs to Self-Medicate for Depression, Anxiety and Trauma
The most common supervisor was a friend or partner, followed by a shamen (a spiritual practitioner), a therapist or counsellor and a family member. The most commonly used substances taken under supervision were LSD, magic mushrooms and ayahuasca.
LSD May Offer Viable Treatment for Anxiety and Other Mental Disorders
Psychedelic drugs, including LSD, were popular in the 1970s and have been gaining popularity over the past decade, with reports of young professionals claiming to regularly take small non-hallucinogenic micro-doses of LSD to boost their productivity and creativity and to increase their empathy.
The Next Revolution in Antidepressants Is Here – LSD, Psilocybin, MDMA, Ketamine & DMT
Psychedelic drugs essentially work opposite of an SSRI. While an SSRI inhibits serotonin processing in the brain to keep a more steady supply, psychedelics flood the brain’s neurotransmitters with chemical compounds present in the drugs that are similar to serotonin.
The Ultimate Guide to Microdosing LSD
Microdosing is the act of consuming sub-perceptual (unnoticeable) amounts of a psychedelic substance. Many individuals who have integrated microdosing LSD into their weekly routine report higher levels of creativity, more energy, increased focus, and improved relational skills, as well as reduced symptoms of depression. Some enthusiasts also report that microdosing LSD has helped them heighten their spiritual awareness and enhance their senses.
Can LSD Treat Your Mental Illness?
For several decades, psychedelics have been uniformly outlawed, with [...]
Psychedelic Drugs Market 2021 Worth Observing Growth | Global Players – Klarisana, AstraZeneca, F. Hoffmann-La Roche, Dr. Reddy’s Laboratories GalleryPsychedelic Drugs Market 2021 Worth Observing Growth | Global Players – Klarisana, AstraZeneca, F. Hoffmann-La Roche, Dr. Reddy’s Laboratories
5-MEO-DMT, Articles & News, Ayahuasca, DMT, Iboga, Ibogaine, LSD, Magic Mushrooms, MDMA, Mescaline, Psychedelic News
Psychedelic Drugs Market 2021 Worth Observing Growth | Global Players – Klarisana, AstraZeneca, F. Hoffmann-La Roche, Dr. Reddy’s Laboratories
The Psychedelic Drugs market is growing rapidly due to the increasing prevalence of depression and other mental disorders worldwide. The need for handling environmental stress and enhanced and better quality of lifestyle is acting as a driver for the Psychedelic Drugs market.
Psychedelics And Schizophrenia: What’s The Link?
A 2018 study provides further clarity on the relationship between psychedelics and schizophrenia. Both break down the barriers between self and other. We know LSD does this by quieting parts of the brain related to ego we’re back to the influence on the 5-HT2A receptors again. (We’re unclear why this occurs in schizophrenics.)
MindMed to Study Potential ‘Off Switch’ for LSD
Psychedelic medicine biotech firm MindMed has announced it has begun a study for a “neutralizer” technology that could shorten and stop the effects of an LSD trip during therapy, paving the way for an “emergency shut-off switch” for psychedelic-assisted therapy.